BIOMARIN PHARMA INC (BMRN)

Overview Price 37.76 Price Change Today -$0.58 (-1.51%) P&P rating Zacks Rank 5 - STRONG SELL Open Price $37.01 Previous Close $38.34 Daily Range $37.01 - $38.44 52-Week Range $23.09 - $38.66 Volume 1,607,256 BioMarin Pharmaceutical Inc. is a developer of carbohydrate enzyme therapies for debilitating, life-threatening, chronic genetic disorders and other diseases and conditions. The company completed a six-month evaluation of patients being treated with BioMarin's lead product, BM101, for the treatment of mucopolysaccharidosis-I, or MPS-I. Patients were treated with BM101 as part of a pivotal clinical trial completed to determine the safety and efficacy of the drug in humans. Other Resources for BMRN Detailed Quote Earnings Estimates Company Report Interactive Chart Commentary Zacks Blog: Zacks #5 Rank Additions for Wednesday February 8, 2012 Zacks Blog: Qiagen Expands with New Deals January 12, 2012 Zacks Blog: BioMarin's Facility Expansion Backed December 22, 2011 Zacks Blog: Pipeline Progress at BioMarin December 1, 2011 Zacks Blog: Facility Expansion at BioMarin November 29, 2011 BioMarin Pharmaceutical Inc. is a developer of carbohydrate enzyme therapies for debilitating, life-threatening, chronic genetic disorders and other diseases and conditions. The company completed a six-month evaluation of patients being treated with BioMarin's lead product, BM101, for the treatment of mucopolysaccharidosis-I, or MPS-I. Patients were treated with BM101 as part of a pivotal clinical trial completed to determine the safety and efficacy of the drug in humans.   Brokerage Analyst Recommendations 14 Brokerage Firms Covering BMRN   Strong Buy 9 Buy 1 Hold 4 Sell 0 Strong Sell 0 Average Broker Recommendation (ABR): 1.64   BMRN Ratings: BUY  SELL  HOLD BMRN Consensus Forecasts

Rate this Stock! You haven't rated this stock yet! Ticker Call Buy Sell Analysis Time Frame Week or Less Week to a Month One to Three Months Three to Six Months Six Months to a Year One to Three Years Three Plus Years What The Community Thinks Total Players 33 Buy 1 Sell   Top Buy Analysis BUY: BMRN Company: BIOMARIN PHARMACEUTICAL INC. Points: 66.13 Start Price: $19.65 Start Date: 05/26/2010 7:49 PM Yade P&P Score: 99.88 Recs: Small Patient Base, Big Opportunity Comments: 0 | Comment More Recent Analysis Top Sell Analysis SELL: BMRN Company: BIOMARIN PHARMACEUTICAL INC. Points: -15.04 Start Price: $35.36 Start Date: 01/01/2008 12:00 AM scaramouche P&P Score: 31.39 Recs: Comments: 0 | Comment More Recent Analysis

Blog Posts

User	User Score	Date	Title	Comments	Last Comment
Zacks_Analysts	0.00	01/12/12	Qiagen Expands with New Deals - Analyst Blog	0
Zacks_Analysts	0.00	12/22/11	BioMarin's Facility Expansion Backed - Analyst Blog	0
Zacks_Analysts	0.00	12/01/11	Pipeline Progress at BioMarin - Analyst Blog	0
Zacks_Analysts	0.00	11/29/11	Facility Expansion at BioMarin - Analyst Blog	0
Zacks_Analysts	0.00	11/16/11	BioMarin Upped to Neutral - Analyst Blog	0
Zacks_Analysts	0.00	10/17/11	BioMarin Downgraded - Analyst Blog	0
Zacks_Analysts	0.00	07/15/11	BioMarin Starts Study on BMN673 - Analyst Blog	0
Zacks_Analysts	0.00	06/27/11	BioMarin to Buy Pfizer Plant - Analyst Blog	0
Zacks_Analysts	0.00	06/08/11	BioMarin Initiates Late-Stage Study - Analyst Blog	0
Zacks_Analysts	0.00	05/26/11	Rules-Based Medicine Hits New High - Analyst Blog	0

Pages: [ 1 ]  2   3   4  >>

Commentary

BUY: BIOMARIN PHARMACEUTICAL INC. (BMRN) Start Price: $19.65 Points: +66.13 Created: 05/26/2010 Small Patient Base, Big Opportunity Comments: 0 | Comment Yade Recs:

BUY: BIOMARIN PHARMACEUTICAL INC. (BMRN) Start Price: $27.01 Points: +28.24 Created: 09/21/2008 Been beating estimates. New drugs in development should help stock price over time. Comments: 0 | Comment DemonSeed Recs:

BUY: BIOMARIN PHARMACEUTICAL INC. (BMRN) Start Price: $26.03 Points: +39.14 Created: 06/12/2011 Comments: 0 | Comment dmb Recs:

BUY: BIOMARIN PHARMACEUTICAL INC. (BMRN) Start Price: $18.64 Points: +54.08 Created: 01/07/2009 Comments: 0 | Comment LeveneOMurray Recs:

BUY: BIOMARIN PHARMACEUTICAL INC. (BMRN) Start Price: $35.36 Points: +15.04 Created: 01/01/2008 Comments: 0 | Comment witty Recs:

BUY: BIOMARIN PHARMACEUTICAL INC. (BMRN) Start Price: $35.36 Points: +15.04 Created: 01/01/2008 Comments: 0 | Comment Durango Recs:

BUY: BIOMARIN PHARMACEUTICAL INC. (BMRN) Start Price: $35.36 Points: +15.04 Created: 01/01/2008 Comments: 0 | Comment Professor7 Recs:

BUY: BIOMARIN PHARMACEUTICAL INC. (BMRN) Start Price: $35.36 Points: +15.04 Created: 01/01/2008 Comments: 0 | Comment doll Recs:

BUY: BIOMARIN PHARMACEUTICAL INC. (BMRN) Start Price: $35.36 Points: +15.04 Created: 01/01/2008 Comments: 0 | Comment allislost Recs:

BUY: BIOMARIN PHARMACEUTICAL INC. (BMRN) Start Price: $35.36 Points: +15.04 Created: 01/01/2008 Comments: 0 | Comment Vayloe Recs:

Pages: [ 1 ]  2   3   4  >>

Picks

Username	P&P Score	Call	Time Frame	Start Date	Start Price	Today (change)	Stock Gain	S&P Gain	Points	Analysis
dmb	0.28	BUY	One to Three Months	06/12/2011	$26.03	$37.83 (-0.71%)	+45.33%	+6.20%	+39.14
Yade	99.88	BUY	One to Three Years	05/26/2010	$19.65	$37.83 (-0.71%)	+92.52%	+26.39%	+66.13	view close
LeveneOMurray	0.70	BUY	Week or Less	01/07/2009	$18.64	$37.83 (-0.71%)	+102.95%	+48.87%	+54.08
DemonSeed	85.95	BUY	One to Three Years	09/21/2008	$27.01	$37.83 (-0.71%)	+40.06%	+11.82%	+28.24	view close
witty	27.56	BUY	Six Months to a Year	01/01/2008	$35.36	$37.83 (-0.71%)	+6.99%	-8.05%	+15.04
Durango	40.94	BUY	Six Months to a Year	01/01/2008	$35.36	$37.83 (-0.71%)	+6.99%	-8.05%	+15.04
Professor7	73.62	BUY	Six Months to a Year	01/01/2008	$35.36	$37.83 (-0.71%)	+6.99%	-8.05%	+15.04
doll	57.42	BUY	Six Months to a Year	01/01/2008	$35.36	$37.83 (-0.71%)	+6.99%	-8.05%	+15.04
allislost	72.43	BUY	Six Months to a Year	01/01/2008	$35.36	$37.83 (-0.71%)	+6.99%	-8.05%	+15.04
Vayloe	53.65	BUY	Six Months to a Year	01/01/2008	$35.36	$37.83 (-0.71%)	+6.99%	-8.05%	+15.04

Pages: [ 1 ]  2   3   4  >>